Morgan Stanley’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $6.08K | Buy |
|
|||||
|
2023
Q3 | $2.84K | Sell |
|
|||||
|
2023
Q2 | $15.5K | Sell |
|
|||||
|
2023
Q1 | $228K | Buy |
|
|||||
|
2022
Q4 | $49.9K | Sell |
|
|||||
|
2022
Q3 | $133K | Sell |
|
|||||
|
2022
Q2 | $645K | Buy |
|
|||||
|
2022
Q1 | $600K | Buy |
|
|||||
|
2021
Q4 | $992K | Buy |
|
|||||
|
2021
Q3 | $56K | Buy |
|
|||||
|
2021
Q2 | $1K | Buy |
|